Contractors / Sanofi Vaccines US Inc.
Sanofi Vaccines US Inc.
prime recipient of federal awards · UEI NCXBGGQ8YTU9 ✓ from source
$1.1B
obligated · FY2025
5
funding agencies
98%
from Health and Hum…
36%
single-source
5
states
6%
in Pennsylvania
6
industries
≈ computedSingle-source: 36% of this recipient’s $72.7M in federal contracts was awarded without competition (FPDS extent-competed codes); the rest was competed or unclassified. A high share often reflects sole-source or specialized work, not wrongdoing.
Obligations by year
≈ computed$579.6M
FY23
$1.6B
FY24
$1.1B
FY25
▲ 96%
since FY23
Where this money comes from
✓ from sourceFUNDING AGENCIES
SANOFI VACCINES US INC.
HHS
$1.1B
4 other agencies
$0B
Sanofi Vaccines US Inc.
$1.1B
FY2025 obligated
Biggest awards (total value)
awarded 2015$201.5M
awarded 2013$102M
Total value over each award’s life, for awards active in FY2025: a decades-long contract can exceed one year’s obligations above.
What it does (NAICS / PSC)
Where the work lands
Pennsylvania✓ from source$72.8M
Oklahoma✓ from source$72.4K
District Of Columbia✓ from source$38.8K
New Jersey✓ from source$8.8K
Competitors
Mckesson Corporation≈ computed$11.9B
Glaxosmithkline, LLC≈ computed$958.8M
Pfizer Inc≈ computed$700.6M
Alvogen, Inc.≈ computed$227.7M
Bavarian Nordic A/S≈ computed$143.6M
DMS Pharmaceutical Group Inc≈ computed$4.3M
Baylor College of Medicine≈ computed$3.1M
Trillamed LLC≈ computed$1.5M
computed from shared NAICS, not a stated rivalry.
Corporate family
Single registration: no combined family.
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.